Cardiorespiratory Fitness, Apolipoprotein E Genotype, and Cognitive Functions: A Prospective Study
NCT ID: NCT05652140
Last Updated: 2024-11-15
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
159 participants
OBSERVATIONAL
2018-07-01
2021-05-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Exercise and Neurocognition in Adults Relative to ApoE Genotype
NCT05101174
Acute Exercise on Neurocognitive Function Among Adults With/Without Generic Risk of AD
NCT05591313
Effects of Combined Motor and Cognitive Training in Pre-frail Elderly
NCT04605809
Health-related Physical Fitness and Executive Function in Older Adults: A Prospective Study
NCT07048561
The Effect of Cardiopulmonary and Muscular Fitness on Healthy Aging Among Community-Dwelling Older Adults
NCT04957381
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1. An exploration of the associations of, as well as the interactions between, CRF assessed at the Baseline Stage, and the ApoE genotype, along with cognitive functions in cognitively healthy late-middle-aged older adults.
2. The employing of an event-related potential (ERP) to investigate the associations between the baseline CRF, the ApoE genotype, and cognitive functions in cognitively healthy late-middle-aged older adults, as well as the potential underlying neuroelectrical mechanisms.
3. An investigation of the interactions between the changes of CRFs assessed at the Baseline and the Follow-Up Stages and the ApoE genotype in relation to neurocognitive function, as well as the underlying neuroelectrical mechanisms, in cognitively healthy late-middle-aged older adults.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
High-Risk with increased CRF
ApoE e4 carriers with increased CRF from Baseline to the Follow-Up Stages.
Data collections
Data collections of cognitive function, neuroelectrical activities, ApoE genotype, and physical fitness.
High-Risk with decreased CRF
ApoE e4 carriers with decreased CRF from Baseline to the Follow-Up Stages.
Data collections
Data collections of cognitive function, neuroelectrical activities, ApoE genotype, and physical fitness.
Low-Risk with increased CRF
Non-ApoE e4 carriers with increased CRF from Baseline to the Follow-Up Stages.
Data collections
Data collections of cognitive function, neuroelectrical activities, ApoE genotype, and physical fitness.
Low-Risk with decreased CRF
Non-ApoE e4 carriers with decreased CRF from Baseline to the Follow-Up Stages.
Data collections
Data collections of cognitive function, neuroelectrical activities, ApoE genotype, and physical fitness.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Data collections
Data collections of cognitive function, neuroelectrical activities, ApoE genotype, and physical fitness.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* no history of cardiorespiratory disease
* normal or corrected-to-normal vision based on the 20/20 standard
* no risk of performing physical activities, as measured by the Physical Activity Readiness Questionnaire
Exclusion Criteria
* history of psychiatric or neurological diseases
* color-blindness
50 Years
70 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Taiwan Normal University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Yu-Kai Chang
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Yu-Kai Chang, Ph.D.
Role: STUDY_DIRECTOR
Department of Physical Education and Sport Sciences, National Taiwan Normal University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Physical Education and Sport Sciences, National Taiwan Normal University
Taipei, , Taiwan
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PACNL_APOE_PROSPECTIVE
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.